Development of Deferoxamine‐Functionalized Cyclodextrin Polymer for Targeted Iron Chelation DOI Creative Commons
Roberta Panebianco, Maurizio Viale, Graziella Vecchio

и другие.

ChemistryOpen, Год журнала: 2025, Номер unknown

Опубликована: Апрель 7, 2025

Polymeric systems are used in clinical settings to bind small molecules and ions. They show advantages pharmacokinetics reduced side effects compared low‐molecular‐weight agents. In this study, a cross‐linked β‐cyclodextrin polymer is functionalized with deferoxamine develop more efficient ways of delivering iron chelators. Deferoxamine well‐known chelator treat overload conditions. The resulting polymeric conjugate, an equal complexing capacity deferoxamine, showed significantly lower cytotoxicity free all cancer cell lines studied (neuroblastoma SHSY5Y, breast MDA‐MB‐231, ovarian adenocarcinoma A2780, lung A549). results demonstrate that the conjugation reduces toxicity at same reveals potential deferoxamine‐based cyclodextrin conjugates as novel approach for targeting dyshomeostasis.

Язык: Английский

Cationic Cyclodextrin-Based Carriers for Drug and Nucleic Acid Delivery DOI Creative Commons
Adila Nazli, Milo Malanga, Tamás Sohajda

и другие.

Pharmaceutics, Год журнала: 2025, Номер 17(1), С. 81 - 81

Опубликована: Янв. 9, 2025

Cyclodextrins can serve as carriers for various payloads, utilizing their capacity to form unique host-guest inclusion complexes within cavity and versatile surface functionalization. Recently, cationic cyclodextrins have gained considerable attention, they improve drug permeability across negatively charged cell membranes efficiently condense nucleic acid due electrostatic interactions. This review focuses on state-of-the-art recent advances in the construction of cyclodextrin-based delivery systems. First, we identified different moieties that are commonly employed design with enhanced complexation ability. Subsequently, a wide range systems were analyzed emphasis chemistry, release profiles, therapeutic outcomes. The evaluation platforms was also based four major types drugs, such anticancer, anti-inflammatory, antibacterial, antidiabetic agents. acids summarized while focusing condensation ability, transfection efficiency, biocompatibility comparison commercially available vectors PEI 25 kDa lipofectamine 2000. Furthermore, highlighted potential constructing multimodal simultaneous encapsulation both drugs acids. Finally, challenges limitations associated cyclodextrin setups discussed.

Язык: Английский

Процитировано

0

Development of Deferoxamine-Functionalized Cyclodextrin Polymer for Targeted Iron Chelation DOI
Graziella Vecchio, Roberta Panebianco, Maurizio Viale

и другие.

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

A Mini-Review on Enhancing Solubility in Topical Hydrogel Formulations Using Solid Dispersion Technology for Poorly Water-Soluble Drugs DOI Creative Commons

Zaid Dahma,

Covadonga Álvarez-Álvarez, Paloma Marina de la Torre-Iglesias

и другие.

Colloids and Interfaces, Год журнала: 2025, Номер 9(2), С. 17 - 17

Опубликована: Март 21, 2025

The solubility behavior of drugs is a critical factor in formulation development. Approximately 40–45% new face market entry challenges due to low water solubility. Enhancing drug bioavailability thus essential developing pharmaceutical dosage forms. Many biopharmaceutical class II and IV are commonly prescribed treat inflammations, infections, pain from various pathologies. Their oral administration has several drawbacks, including significant first-pass liver effects, bioavailability, adverse gastrointestinal effects. Topical application gained relevance its advantages delivering directly the target site, avoiding irritation, increasing their effectiveness. However, topical hydrogel formulations with poorly water-soluble related skin’s permeability. Therefore, preparing hydrogels using solid dispersions (SDs) an effective strategy enhance dissolution rate soluble drugs, thereby improving bioavailability. In this review, concepts SDs, delivery systems, incorporating as well preparation methods, characterization, applications, will be discussed.

Язык: Английский

Процитировано

0

Development of Deferoxamine‐Functionalized Cyclodextrin Polymer for Targeted Iron Chelation DOI Creative Commons
Roberta Panebianco, Maurizio Viale, Graziella Vecchio

и другие.

ChemistryOpen, Год журнала: 2025, Номер unknown

Опубликована: Апрель 7, 2025

Polymeric systems are used in clinical settings to bind small molecules and ions. They show advantages pharmacokinetics reduced side effects compared low‐molecular‐weight agents. In this study, a cross‐linked β‐cyclodextrin polymer is functionalized with deferoxamine develop more efficient ways of delivering iron chelators. Deferoxamine well‐known chelator treat overload conditions. The resulting polymeric conjugate, an equal complexing capacity deferoxamine, showed significantly lower cytotoxicity free all cancer cell lines studied (neuroblastoma SHSY5Y, breast MDA‐MB‐231, ovarian adenocarcinoma A2780, lung A549). results demonstrate that the conjugation reduces toxicity at same reveals potential deferoxamine‐based cyclodextrin conjugates as novel approach for targeting dyshomeostasis.

Язык: Английский

Процитировано

0